Verdence Capital Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-15,077	Closed	-$230K	–	264
2018 Q2	$230K	Buy	15,077 +2,500	+20%	+$38.1K	0.06%	249
2018 Q1	$283K	Hold	12,577	–	–	0.07%	227
2017 Q4	$379K	Buy	+12,577	New	+$379K	0.09%	183